John Jefferies' Stock Options and Common Stock Holdings in Daxor Corp
2025-10-02SEC Filing 3 (0001493152-25-016669)
John Jefferies, the Chief Medical Officer of Daxor Corp, holds significant stock options and common stock in the company. The filing details multiple stock options with varying expiration dates between 2026 and 2028, with exercise prices ranging from $9.09 to $13.96. Additionally, Jefferies owns 15,272 shares of Daxor Common Stock. The stock options are exercisable in full, with some vesting in three equal installments starting December 1, 2023. This filing provides a comprehensive view of Jefferies' equity holdings in Daxor Corp, highlighting his vested interest in the company's performance.
Tickers mentioned in this filing:DXR
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/27367/0001493152-25-016669.txt